These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24922195)

  • 1. Elevated serum levels of calprotectin (myeloid-related protein 8/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life.
    Oktayoglu P; Bozkurt M; Mete N; Caglayan M; Em S; Nas K
    J Investig Med; 2014 Aug; 62(6):880-4. PubMed ID: 24922195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis.
    Duran A; Kobak S; Sen N; Aktakka S; Atabay T; Orman M
    Bosn J Basic Med Sci; 2016 Jan; 16(1):71-4. PubMed ID: 26773186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index in Turkish patients with ankylosing spondylitis: relationship with disease activity and quality of life.
    Zahiroglu Y; Ulus Y; Akyol Y; Tander B; Durmus D; Bilgici A; Kuru O
    Int J Rheum Dis; 2014 Feb; 17(2):173-80. PubMed ID: 24576273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.
    Jarlborg M; Courvoisier DS; Lamacchia C; Martinez Prat L; Mahler M; Bentow C; Finckh A; Gabay C; Nissen MJ;
    Arthritis Res Ther; 2020 May; 22(1):105. PubMed ID: 32375861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.
    Klingberg E; Carlsten H; Hilme E; Hedberg M; Forsblad-d'Elia H
    Scand J Gastroenterol; 2012 Apr; 47(4):435-44. PubMed ID: 22229862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S).
    Zochling J
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S47-58. PubMed ID: 22588768
    [No Abstract]   [Full Text] [Related]  

  • 8. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study.
    Matzkies FG; Targan SR; Berel D; Landers CJ; Reveille JD; McGovern DP; Weisman MH
    Arthritis Res Ther; 2012 Nov; 14(6):R261. PubMed ID: 23194008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
    Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
    J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life.
    Oktayoglu P; Em S; Tahtasiz M; Bozkurt M; Ucar D; Yazmalar L; Nas K; Yardımeden I; Cevik F; Celik Y; Mete N
    Rheumatol Int; 2013 May; 33(5):1327-31. PubMed ID: 23143556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum procalcitonin levels in patients with ankylosing spondylitis.
    Ozmen M; Oktay E; Tarhan EF; Aslan O; Oflazoglu U; Koseoglu MH
    Int J Rheum Dis; 2016 May; 19(5):500-5. PubMed ID: 24798190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
    Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
    Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminating Value of Calprotectin in Disease Activity and Progression of Nonradiographic Axial Spondyloarthritis and Ankylosing Spondylitis.
    Huang J; Yin Z; Song G; Cui S; Jiang J; Zhang L
    Dis Markers; 2017; 2017():7574147. PubMed ID: 28630526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic calprotectin and chronic inflammatory rheumatic diseases.
    Romand X; Bernardy C; Nguyen MVC; Courtier A; Trocme C; Clapasson M; Paclet MH; Toussaint B; Gaudin P; Baillet A
    Joint Bone Spine; 2019 Nov; 86(6):691-698. PubMed ID: 30660804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
    Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
    J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway.
    Solmaz D; Uslu S; Kozacı D; Karaca N; Bulbul H; Tarhan EF; Ozmen M; Can G; Akar S
    Int J Rheum Dis; 2018 Feb; 21(2):502-509. PubMed ID: 28941122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum calprotectin correlates with risk and disease severity of ankylosing spondylitis and its change during first month might predict favorable response to treatment.
    Hu H; Du F; Zhang S; Zhang W
    Mod Rheumatol; 2019 Sep; 29(5):836-842. PubMed ID: 30175641
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.
    Li XL; Lin TT; Qi CY; Yuan L; Xia LP; Shen H; Lu J
    J Investig Med; 2013 Jun; 61(5):848-51. PubMed ID: 23552178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis.
    Deniz T; Kizilgul M; Uzunlulu M; Oguz A; Isbilen B
    Acta Reumatol Port; 2014; 39(2):137-42. PubMed ID: 24861165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.